
Translational research pipelines accelerate or stall based on the infrastructure connecting animal studies to clinical application—and institutions that treat the vivarium as a support function rather than a strategic asset tend to find out too late. Joe Petrosino describes how BCM positioned its new vivarium as the operational foundation of an integrated ecosystem including CGMP manufacturing, preclinical development, and early-phase clinical research. He outlines the planning criteria used to determine scale, program mix, and departmental adjacencies, and addresses how leadership secured stakeholder alignment around a capital investment framed as a driver of institutional research competitiveness.
| Occurs |
|---|
|
Thursday August 27th 8:40AM - 9:05AM
|
